Welcome to our dedicated page for Cencora news (Ticker: COR), a resource for investors and traders seeking the latest updates and insights on Cencora stock.
Cencora, Inc. (NYSE: COR) is a premier global pharmaceutical solutions provider committed to enhancing healthcare delivery and improving lives worldwide.
As one of the top three pharmaceutical wholesalers in the United States, Cencora specializes in sourcing and distributing branded, generic, and specialty pharmaceutical products to a diverse range of clients, including retail chains, independent pharmacies, mail-order services, hospital networks, and healthcare providers. In collaboration with McKesson and Cardinal Health, Cencora dominates over 90% of the U.S. pharmaceutical wholesale market.
Beyond its robust domestic operations, Cencora has significantly expanded its international footprint. Notably, the acquisition of Alliance Healthcare in 2021 bolstered its presence in Europe, making it one of the leading drug wholesalers in the region.
Additionally, Cencora offers comprehensive commercialization services for pharmaceutical and medical device manufacturers. Its global specialty drug logistics division, World Courier, is renowned for its precision and reliability. The company also extends its expertise to animal health product distribution through MWI Animal Health.
Cencora's strategic partnerships and innovative solutions drive operational efficiency, cost control, and growth opportunities across the healthcare supply chain.
- Its pharmacy solutions enhance operational efficiency, cost control, growth opportunities, and patient safety.
- Provider solutions focus on improving operational efficiency, financial performance, and quality of care.
- Manufacturer solutions are designed to maximize success at every stage of the product lifecycle.
Recent achievements include a distribution agreement with Sapphiros, enhancing access to COVID-19 Antigen Rapid Tests and future diagnostic technologies in the U.S. market. This partnership is poised to bring innovative diagnostic solutions directly to patients, exemplifying Cencora's commitment to improving accessibility and convenience in healthcare.
Cencora’s mission is driven by a strong sense of purpose: 'We are united in our responsibility to create healthier futures.' Ranked #11 on the Fortune 500 and #24 on the Global Fortune 500, with annual revenues exceeding $250 billion, Cencora’s over 46,000 team members worldwide are dedicated to delivering positive health outcomes through their expertise and collaborative efforts.
CoreSite Realty Corporation, a subsidiary of American Tower, announced tax reporting information for its 2021 distributions. Following the acquisition by American Tower on December 28, 2021, CoreSite's shares ceased trading on the NYSE. Stockholders are advised to consult tax advisors regarding their specific tax treatment. For the year, CoreSite reported cash distributions per share, including ordinary taxable dividends and capital gain distributions, emphasizing that there were no non-dividend distributions for the tax year ending December 28, 2021.
American Tower Corporation (NYSE: AMT) has successfully completed its acquisition of CoreSite Realty Corporation (NYSE: COR) following a tender offer for CoreSite's outstanding shares. The acquisition was financed through borrowings under American Tower’s credit facilities and term loans. CEO Tom Bartlett expressed optimism about leveraging CoreSite's data centers to enhance growth opportunities amidst the rise of 5G and cloud services. The acquisition is expected to be modestly accretive to American Tower’s AFFO per Share initially, with potential for increased accretion over time.
FAQ
What is the current stock price of Cencora (COR)?
What is the market cap of Cencora (COR)?
What does Cencora, Inc. do?
Who are Cencora's main clients?
What are some recent achievements of Cencora?
How significant is Cencora in the U.S. pharmaceutical wholesale market?
What international presence does Cencora have?
What other services does Cencora provide?
What is Cencora’s mission?
How is Cencora ranked on the Fortune 500?
What is the scale of Cencora's operations?
What are some key solutions provided by Cencora?
